HK이노엔(195940) IR & PR 공식채널

안녕하십니까 HK이노엔 IR팀입니다. 당사 소화성궤양신약 케이캡이 국내에 이어 전세계 대형시장인 중국에서도 출시 3년만에 시장내 1위품목으로 성장하여 관련 기사자료를 공유드립니다. https://www.medicopharma.co.kr/news/articleView.html?idxno=68833

금일 발간된 증권사 리포트 공유드립니다. (Sharing reports published today)

HK inno.N Ranked No. 1 in Sustinvest ESG Evaluation - No. 1 among companies with assets of KRW 2 trillion or more — the 5th consecutive ranking No. 1 in its size grade - Published the '2025 Sustainability Report'; strengthened its management system by building an ESG data platform HK inno.N announced on July 1 that it received the highest grade (AA) in the '1H 2026 ESG Evaluation' released by ESG rating agency Sustinvest, and was ranked No. 1 among companies with assets of KRW 2 trillion or more. Sustinvest is one of Korea’s leading ESG rating agencies, conducting ESG evaluations of domestic companies in the first and second half of each year. The 1H 2026 evaluation covered 1,305 Korean companies. According to the results, HK inno.N ranked No. 1 in the KRW 2 trillion-plus asset group within the “ESG Best Companies 100” — the 100 listed companies that demonstrated outstanding performance across all environmental, social, and governance areas. With this result, HK inno.N has ranked No. 1 in its size grade for five consecutive half-year periods since the first half of 2024. Notably, the 1H 2026 evaluation was the first conducted since HK inno.N joined the group of companies with assets of KRW 2 trillion or more. Outpacing major Korean corporations, the company proved its standing as an ESG-leading firm — a result of significant meaning. In the environmental area, HK inno.N made visible its greenhouse gas reduction effect from the transition to renewable energy by signing a third-party power purchase agreement (PPA). In the social area, it systematically conducted overseas supply chain due diligence to manage its global supply chain. In the governance area, it established a CEO succession policy to build a transparent and stable management system. HK inno.N published its '2025 Sustainability Report,' which contains its ESG management strategy and performance, on June 30. The report was fully revamped from the previous horizontal layout to the vertical format, the standard disclosure form. In addition, the company built a company-wide ESG data platform, dramatically enhancing the consistency and reliability of its data. Kwak Dal-won, CEO of HK inno.N, said, “This is a meaningful result, recognizing our ESG performance not only in the pharmaceutical and bio industry but across all industries,” adding, “We will continue to take the lead in spreading sustainable value across the environmental, social, and governance areas.”